Trials / Withdrawn
WithdrawnNCT01710410
Transcranial Direct Current Stimulation in a Smoking Cessation Trial
Pilot Study of Transcranial Direct Current Stimulation (tDCS) as a Smoking Cessation Treatment for Nicotine Dependent Smokers
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre for Addiction and Mental Health · Academic / Other
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effectiveness of transcranial direct current stimulation (tDCS) plus nicotine patch as a viable smoking cessation program for nicotine dependent smokers.
Detailed description
BACKGROUND: Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation that involves the application of brief weak electric current to the scalp. tDCS may induce neuroplasticity, thereby engaging some of the same systems that figure prominently in the pathological neuroplasticity caused by addictive drugs. OBJECTIVE: To assess whether tDCS delivered along with nicotine patch reliably increases a) quit rates, b) duration of abstinence, and c) percentage of participants abstinent at follow-up. METHOD: Active (20min; 2mA) and sham (30sec; 2mA) stimulation will be applied to the dorsolateral prefrontal cortex (DLPFC) in both cerebral hemispheres. HYPOTHESES: 1. Active tDCS (20-min; 2 mA) will increase abstinence in a standard smoking cessation protocol relative to a sham procedure. 2. The benefits of active left anodal stimulation (anode-left/cathode-right) to the DLPFC will be greater than of active tDCS in the reverse configuration (cathode-left/anode-right).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | active transcranial Direct Current Stimulation | Brief (20-min) application of weak electric current (e.g., 2 mA) to the scalp. |
| DEVICE | sham transcranial Direct Current Stimulation | Brief (30-sec) application of weak electric current (e.g., 2mA) to the scalp. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2012-10-19
- Last updated
- 2016-06-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01710410. Inclusion in this directory is not an endorsement.